Flagship explainer
How ADAPTIVE BIOTECHNOLOGIES CORPORATION makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $277M | 100% |
| |
| Cost of revenue | $71.4M | 26% |
|
| $206M | 74% |
| |
| −$57.1M | −21% |
| |
| Income before tax | −$59.5M | −21% |
|
| Income tax | $0 | 0% |
|
| −$59.5M | −21% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001193125-26-076902